Christopher Mulgrew - 31 Dec 2021 Form 5 Insider Report for Hawkeye Systems, Inc. (HWKE)

Role: CFO and Director, Director
Signature: /s/ Gilbert J. Bradshaw, Attorney-in- Fact for Christopher Mulgrew
Issuer symbol: HWKE
Transactions as of: 31 Dec 2021
Net transactions value: $0
Form type: 5
Filing time: 11 Mar 2024, 17:33:36 UTC
Next filing: 30 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HWKE	Common Stock	Award		+620,000			620,000	03 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HWKE	Stock Options	Award	$0	+375,000	+300%	$0.000000	500,000	01 Mar 2021	Common Stock	375,000	$0.3000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 620,000 restricted shares of the Issuer's Common Stock by the Company's board of directors and were issued on November 3, 2021 in exchange for deferred compensation.
F2	On January 15, 2021, the Company entered into a consulting agreement with the Reporting Person (the "Consulting Agreement"). The Consulting Agreement was amended and restated on March 1, 2021 (the "Restated Agreement"). Pursuant to the terms of the Restated Agreement, the Company shall issue stock options to acquire 500,000 shares of the Issuer's Common Stock at $0.30 per share, with 20% of the stock options vesting immediately upon issuance of the option, and an additional 20% every three months thereafter. As reflected here, the terms of the Restated Agreement impacted certain details surrounding the grant of stock options that was previously reported in the Form 3 filed for the Reporting Person with the SEC on April 1, 2021.

Content

The Reporting Person was granted 620,000 restricted shares of the Issuer's Common Stock by the Company's board of directors and were issued on November 3, 2021 in exchange for deferred compensation.

On January 15, 2021, the Company entered into a consulting agreement with the Reporting Person (the "Consulting Agreement"). The Consulting Agreement was amended and restated on March 1, 2021 (the "Restated Agreement"). Pursuant to the terms of the Restated Agreement, the Company shall issue stock options to acquire 500,000 shares of the Issuer's Common Stock at $0.30 per share, with 20% of the stock options vesting immediately upon issuance of the option, and an additional 20% every three months thereafter. As reflected here, the terms of the Restated Agreement impacted certain details surrounding the grant of stock options that was previously reported in the Form 3 filed for the Reporting Person with the SEC on April 1, 2021.